MP85-18 IVABRADINE (FIRST HCN CHANNEL BLOCKER) ATTENUATES HUMAN CORPUS CAVERNOSUM CONTRACTION IN VITRO VIA INTERFERENCE WITH THE CALCIUM AND POTASSIUM TRANSFER: A POTENTIAL NEW THERAPEUTIC OPTION FOR ERECTILE DYSFUNCTION
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.